Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTION: Goserelin for Ovarian Protection in Breast Cancer
NCT00427245Phase 3Completed
- Sponsor
- Anglo Celtic Cooperative Oncology Group
- Start
- Aug 2004
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of goserelin in primary ovarian insufficiency (POI), sponsored by Anglo Celtic Cooperative Oncology Group. Started Aug 2004; status: completed.
02
Drugs
goserelin
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT00427245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00427245.